RNA Methylation

CAMBRIDGE, UK, May 22, 2026 STORM Therapeutics announced that new Phase 1 data for its first-in-class METTL3 inhibitor STC-15...

HEIDELBERG, Germany, December 16, 2025 — Hummingbird Diagnostics GmbH has published a peer-reviewed study revealing a novel approach to...